Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Metropolis IPO is a book built issue of Rs 1,204.29 crores.
Metropolis IPO bidding started from April 3, 2019 and ended on April 5, 2019. The allotment for Metropolis IPO was finalized on Wednesday, April 10, 2019. The shares got listed on BSE, NSE on April 15, 2019.
Metropolis IPO price band is set at ₹877 to ₹880 per share. The minimum lot size for an application is 17 Shares. The minimum amount of investment required by retail investors is ₹14,960.
Credit Suisse Securities (India) Private Limited, Goldman Sachs (India) Securities Private Limited, Hdfc Bank Limited, Jm Financial Limited and Kotak Mahindra Capital Company Limited are the book running lead managers of the Metropolis IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Metropolis IPO RHP for detailed information.
| IPO Date | April 3, 2019 to April 5, 2019 |
| Listing Date | April 15, 2019 |
| Face Value | ₹2 per share |
| Price Band | ₹877 to ₹880 per share |
| Lot Size | 17 Shares |
| Total Issue Size | 13,685,095 shares (aggregating up to ₹1,204.29 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Metropolis IPO offers 19,708,388 shares. 4,015,529 (20.37%) to QIB, 2,007,764 (10.19%) to NII, 1,338,509 (6.79%) to RII, 300,000 (1.52%) to employees 6,023,293 (30.56%) to Anchor investors. 78,735 RIIs will receive minimum 17 shares and (sNII) and (bNII) will receive minimum 238 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 6,023,293 (30.56%) | NA |
| QIB Shares Offered | 4,015,529 (20.37%) | NA |
| NII (HNI) Shares Offered | 2,007,764 (10.19%) | |
| Retail Shares Offered | 1,338,509 (6.79%) | 78,735 |
| Employee Shares Offered | 300,000 (1.52%) | NA |
| Total Shares Offered | 19,708,388 (100%) |
Metropolis IPO opens on April 3, 2019, and closes on April 5, 2019.
| IPO Open Date | Wednesday, April 3, 2019 |
| IPO Close Date | Friday, April 5, 2019 |
| Basis of Allotment | Wednesday, April 10, 2019 |
| Initiation of Refunds | Thursday, April 11, 2019 |
| Credit of Shares to Demat | Friday, April 12, 2019 |
| Listing Date | Monday, April 15, 2019 |
| Cut-off time for UPI mandate confirmation | 5 PM on April 5, 2019 |
Investors can bid for a minimum of 17 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 17 | ₹14,960 |
| Retail (Max) | 13 | 221 | ₹194,480 |
| Lot Size Calculator | |||
Promoters of the company are:
1. Dr Sushil Kanubhai Shah
2. Ameera Sushil Shah
3. Metz Advisory LLP
| Share Holding Pre Issue | 99.71% |
| Share Holding Post Issue | 49.44% |
Incorporated in 1980, Mumbai based Metropolis Healthcare Limited is a chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening.
The company also provides analytical and support services for the clinical research projects to some clinical research organizations. In the last financial year (2018), approximately 7.7 million patients visited the lab and around 16.0 million tests conducted in the clinics.
Metropolis offers 3,480 clinical laboratory tests and 524 profiles which combines a variety of tests for the specific disease. To provide better services, it has implemented a 'hub and spoke' model. Outside India, the company has a presence in Ghana, Zambia, Kenya, Sri Lanka and Mauritius for laboratory operations and in UAE, Nepal, Nigeria, and Oman for 3rd party services.
It has been recognized by Biotrains for "excellence in customer service and delivery" and FICCI for "service excellence (diagnostic center)" and LH Insights for "best in health and fitness" in 2018.
The competitive strengths of the company are:
1. Well positioned for expected industry growth
2. Widespread operational network
3. Comprehensive test menu
4. Focus on quality and customer service
5. Robust information technology structure
| Particulars | For the year/period ended (in Rs. 10 Lakhs) | |||
|---|---|---|---|---|
| 31-Dec-18 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |
| Total Assets | 5,838.75 | 5,303.40 | 5,151.59 | 3,959.16 |
| Total Revenue | 5,593.06 | 6,435.67 | 5,447.24 | 4,754.69 |
| Profit After Tax | 887.71 | 1,097.47 | 1,072.57 | 819.55 |
The objects of the Offer are:
1. Listing of the Equity Shares will enhance the visibility and
brand image of company.
2. Provide a public market for the Equity
Shares in India.
[Dilip Davda] Although the sector is fragmented and highly unorganized, MHL has created a niche place amongst organized players with many firsts to its credit. Though the issue appears fully priced, asset light and debt-free status make this offer lucrative. Investors may consider an investment for the long term. Read detail review...
The Metropolis IPO is subscribed 5.83 times on April 5, 2019 6:49:02 PM. The public issue subscribed 2.15 times in the retail category, 8.88 times in the QIB category, and 3.03 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 8.88 |
| NII | 3.03 |
| Retail | 2.15 |
| Employee | 0.05 |
| Total | 5.83 |
| Listing Date | April 15, 2019 |
| BSE Script Code | 542650 |
| NSE Symbol | METROPOLIS |
| ISIN | INE112L01020 |
| Final Issue Price | ₹880 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹880.00 |
| ₹960.00 |
| ₹934.80 |
| ₹981.30 |
| ₹959.55 |
| NSE |
|---|
| ₹880.00 |
| ₹958.00 |
| ₹935.00 |
| ₹982.70 |
| ₹959.85 |
Metropolis Healthcare Limited
250 D Udyog Bhavan,
Hind Cycle Marg, Worli
Mumbai 400 030, Maharashtra
Phone: (91 22) 6258 2810
Email: investor.relations@metropolisindia.com
Website: https://www.metropolisindia.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: metropolis.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Lead Manager Reports
Metropolis IPO is a main-board IPO of 13,685,095 equity shares of the face value of ₹2 aggregating up to ₹1,204.29 Crores. The issue is priced at ₹877 to ₹880 per share. The minimum order quantity is 17 Shares.
The IPO opens on April 3, 2019, and closes on April 5, 2019.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Metropolis IPO opens on April 3, 2019 and closes on April 5, 2019.
Metropolis IPO lot size is 17 Shares, and the minimum amount required is ₹14,960.
You can apply in Metropolis IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Metropolis IPO will be done on Wednesday, April 10, 2019, and the allotted shares will be credited to your demat account by Friday, April 12, 2019. Check the Metropolis IPO allotment status.
IPO Guru (1400+ Posts, 1200+ Likes)
Top Contributor (400+ Posts, 200+ Likes)
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Mentor (600+ Posts, 400+ Likes)
